Time matters - Acute stress response and glucocorticoid sensitivity in early multiple sclerosis

Brain, Behavior, and Immunity

Volumn 41, Issue 1, 2014, Pages 82-89

  Kern, Simone ^a   Rohleder, Nicolas ^b   Eisenhofer, Graeme ^a   Lange, Jan ^a   Ziemssen, Tjalf ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b BRANDEIS UNIVERSITY   (United States)

Author keywords

Cortisol; Glucocorticoid sensitivity; Multiple sclerosis; Stress; TSST

Indexed keywords

CATECHOLAMINE; GLATIRAMER; GLUCOCORTICOID; HYDROCORTISONE; INTERFERON; NATALIZUMAB; CYTOKINE; DEXAMETHASONE; LIPOPOLYSACCHARIDE;

ACUTE STRESS; ADULT; ARTICLE; CATECHOLAMINE RELEASE; CHRONIC STRESS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; DISABILITY; DISEASE DURATION; FEMALE; GLUCOCORTICOID SENSITIVITY; HUMAN; HYDROCORTISONE RELEASE; HYPOTHALAMUS HYPOPHYSIS SYSTEM; IMMUNOCOMPETENT CELL; MALE; MENTAL STRESS; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; PHYSICAL SENSITIVITY; PRIORITY JOURNAL; PSYCHOLOGIC TEST; RESPONSE TIME; SELF REPORT; TRIER SOCIAL STRESS TEST; BIOSYNTHESIS; BLOOD; CASE CONTROL STUDY; DEPRESSION; DRUG EFFECTS; HYPOPHYSIS ADRENAL SYSTEM; IC50; IMMUNOMODULATION; LEUKOCYTE; MATHEMATICS; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGY; SPEECH; YOUNG ADULT;

ADULT; CASE-CONTROL STUDIES; CATECHOLAMINES; CYTOKINES; DEPRESSION; DEXAMETHASONE; FEMALE; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INHIBITORY CONCENTRATION 50; LEUKOCYTES; LIPOPOLYSACCHARIDES; MALE; MATHEMATICS; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; NEUROIMMUNOMODULATION; PITUITARY-ADRENAL SYSTEM; SPEECH; STRESS, PSYCHOLOGICAL; YOUNG ADULT;

EID: 84924021207     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2014.04.006     Document Type: Article

References (39)

1. Ackerman K.D., Heyman R., Rabin B.S., Anderson B.P., Houck P.R., Frank E., Baum A. Stressful life events precede exacerbations of multiple sclerosis. Psychosom. Med. 2002, 64:916-920.
2. Ackerman K.D., Martino M., Heyman R., Moyna N.M., Rabin B.S. Immunologic response to acute psychological stress in MS patients and controls. J. Neuroimmunol. 1996, 68:85-94.
3. Artemiadis A.K., Anagnostouli M.C., Alexopoulos E.C. Stress as a risk factor for multiple sclerosis onset or relapse: a systematic review. Neuroepidemiology 2012, 36:109-120.
4. Beck A.T., Ward C.H., Mendelson M., Mock J., Erbaugh J. An inventory for measuring depression. Arch. Gen. Psychiatry 1961, 4:561-571.
5. Besedovsky H.O., del Rey A. Central and peripheral cytokines mediate immune-brain connectivity. Neurochem. Res. 2011, 36:1-6.
6. Biddie S.C., Conway-Campbell B.L., Lightman S.L. Dynamic regulation of glucocorticoid signalling in health and disease. Rheumatology (Oxford, England) 2012, 51:403-412.
7. Buljevac D., Hop W.C., Reedeker W., Janssens A.C., van der Meche F.G., van Doorn P.A., Hintzen R.Q. Self reported stressful life events and exacerbations in multiple sclerosis: prospective study. BMJ 2003, 327:646.
8. del Rey A., Klusman I., Besedovsky H.O. Cytokines mediate protective stimulation of glucocorticoid output during autoimmunity: involvement of IL-1. Am J Physiol 1998, 275:R1146-1151.
9. DeRijk R.H., Eskandari F., Sternberg E.M. Corticosteroid resistance in a subpopulation of multiple sclerosis patients as measured by ex vivo dexamethasone inhibition of LPS induced IL-6 production. J. Neuroimmunol. 2004, 151:180-188.
10. Dickerson S.S., Kemeny M.E. Acute stressors and cortisol responses: a theoretical integration and synthesis of laboratory research. Psychol. Bull. 2004, 130:355-391.
11. Ebrecht M., Buske-Kirschbaum A., Hellhammer D., Kern S., Rohleder N., Walker B., Kirschbaum C. Tissue specificity of glucocorticoid sensitivity in healthy adults. J. Clin. Endocrinol. Metab. 2000, 85:3733-3739.
12. Eisenhofer G., Goldstein D.S., Stull R., Keiser H.R., Sunderland T., Murphy D.L., Kopin I.J. Simultaneous liquid-chromatographic determination of 3,4-dihydroxyphenylglycol, catecholamines, and 3,4-dihydroxyphenylalanine in plasma, and their responses to inhibition of monoamine oxidase. Clin. Chem. 1986, 32:2030-2033.
13. Elenkov I.J., Wilder R.L., Chrousos G.P., Vizi E.S. The sympathetic nerve - an integrative interface between two supersystems: the brain and the immune system. Pharmacol. Rev. 2000, 52:595-638.
14. Filippini, G., Brusaferri, F., Sibley, W.A., Citterio, A., Ciucci, G., Midgard, R., Candelise, L., 2000. Corticosteroids or ACTH for acute exacerbations in multiple sclerosis. Cochrane database of systematic reviews (Online), CD001331.
15. Gaab J., Rohleder N., Nater U.M., Ehlert U. Psychological determinants of the cortisol stress response: the role of anticipatory cognitive appraisal. Psychoneuroendocrinology 2005, 30:599-610.
16. Gold S.M., Sasidhar M.V., Lagishetty V., Spence R.D., Umeda E., Ziehn M.O., Krieger T., Schulz K.H., Heesen C., Hewison M., Voskuhl R.R. Dynamic development of glucocorticoid resistance during autoimmune neuroinflammation. J. Clin. Endocrinol. Metab 2012, 97(8):E1402-E1410.
17. Heesen C., Schulz H., Schmidt M., Gold S., Tessmer W., Schulz K.H. Endocrine and cytokine responses to acute psychological stress in multiple sclerosis. Brain Behav. Immun. 2002, 16:282-287.
18. Kahl K.G., Kruse N., Faller H., Weiss H., Rieckmann P. Expression of tumor necrosis factor-alpha and interferon-gamma mRNA in blood cells correlates with depression scores during an acute attack in patients with multiple sclerosis. Psychoneuroendocrinology 2002, 27:671-681.
19. Kern S., Ziemssen T. Brain-immune communication psychoneuroimmunology of multiple sclerosis. Mult. Scler. 2008, 14:6-21.
20. Kern S., Krause I., Horntrich A., Thomas K., Aderhold J., Ziemssen T. Cortisol awakening response is linked to disease course and progression in multiple sclerosis. PLoS ONE 2013, 8:e60647.
21. Kirschbaum C., Pirke K.M., Hellhammer D.H. The 'Trier Social Stress Test' - a tool for investigating psychobiological stress responses in a laboratory setting. Neuropsychobiology 1993, 28:76-81.
22. Kurtzke J.F. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983, 33:1444-1452.
23. MacPhee I.A., Antoni F.A., Mason D.W. Spontaneous recovery of rats from experimental allergic encephalomyelitis is dependent on regulation of the immune system by endogenous adrenal corticosteroids. J. Exp. Med. 1989, 169:431-445.
24. McEwen B.S., Biron C.A., Brunson K.W., Bulloch K., Chambers W.H., Dhabhar F.S., Goldfarb R.H., Kitson R.P., Miller A.H., Spencer R.L., Weiss J.M. The role of adrenocorticoids as modulators of immune function in health and disease: neural, endocrine and immune interactions. Brain Res. Brain Res. Rev. 1997, 23:79-133.
25. McKay L.I., Cidlowski J.A. Molecular control of immune/inflammatory responses: interactions between nuclear factor-kappa B and steroid receptor-signaling pathways. Endocr. Rev. 1999, 20:435-459.
26. Mohr D.C., Hart S.L., Julian L., Cox D., Pelletier D. Association between stressful life events and exacerbation in multiple sclerosis: a meta-analysis. BMJ 2004, 328:731.
27. Murta V., Ferrari C.C. Influence of peripheral inflammation on the progression of multiple sclerosis: evidence from the clinic and experimental animal models. Mol. Cell. Neurosci. 2013, 53:6-13.
28. Polman C.H., Reingold S.C., Edan G., Filippi M., Hartung H.P., Kappos L., Lublin F.D., Metz L.M., McFarland H.F., O'Connor P.W., Sandberg-Wollheim M., Thompson A.J., Weinshenker B.G., Wolinsky J.S. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann. Neurol. 2005, 58:840-846.
29. Rao U., Hammen C., Ortiz L.R., Chen L.A., Poland R.E. Effects of early and recent adverse experiences on adrenal response to psychosocial stress in depressed adolescents. Biol. Psychiatry 2008, 64:521-526.
30. Rohleder N., Kudielka B.M., Hellhammer D.H., Wolf J.M., Kirschbaum C. Age and sex steroid-related changes in glucocorticoid sensitivity of pro-inflammatory cytokine production after psychosocial stress. J. Neuroimmunol. 2002, 126:69-77.
31. Rohleder N., Wolf J.M., Kirschbaum C. Glucocorticoid sensitivity in humans-interindividual differences and acute stress effects. Stress (Amsterdam, Netherlands) 2003, 6:207-222.
32. Russ T.C., Stamatakis E., Hamer M., Starr J.M., Kivimaki M., Batty G.D. Association between psychological distress and mortality: individual participant pooled analysis of 10 prospective cohort studies. BMJ 2012, 345:e4933.
33. Schommer N.C., Hellhammer D.H., Kirschbaum C. Dissociation between reactivity of the hypothalamus-pituitary-adrenal axis and the sympathetic-adrenal-medullary system to repeated psychosocial stress. Psychosom. Med. 2003, 65:450-460.
34. Schulz P., Schlotz W. The Trier Inventory for Chronic Stress (TICS): scale construction, statistical testing and validation of the scale work overload. Diagnostica 1999, 45:8-19.
35. Sternberg E.M., Chrousos G.P., Wilder R.L., Gold P.W. The stress response and the regulation of inflammatory disease. Ann. Intern. Med. 1992, 117:854-866.
36. van Winsen L.M., Manenschijn L., van Rossum E.F., Crusius J.B., Koper J.W., Polman C.H., Uitdehaag B.M. A glucocorticoid receptor gene haplotype (TthIII1/ER22/23EK/9beta) is associated with a more aggressive disease course in multiple sclerosis. J. Clin. Endocrinol. Metab. 2009, 94:2110-2114.
37. van Winsen L.M., Muris D.F., Polman C.H., Dijkstra C.D., van den Berg T.K., Uitdehaag B.M. Sensitivity to glucocorticoids is decreased in relapsing remitting multiple sclerosis. J. Clin. Endocrinol. Metab. 2005, 90:734-740.
38. van Winsen L.M., Polman C.H., Dijkstra C.D., Tilders F.J., Uitdehaag B.M. Suppressive effect of glucocorticoids on TNF-alpha production is associated with their clinical effect in multiple sclerosis. Mult. Scler. 2010, 16:500-502.
39. Ysrraelit M.C., Gaitan M.I., Lopez A.S., Correale J. Impaired hypothalamic-pituitary-adrenal axis activity in patients with multiple sclerosis. Neurology 2008, 71:1948-1954.